MarketResearch.com logo

Recent Prescription Drugs Research for November 2024


5-Alpha Reductase Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT1 Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT1 Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT1D Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT2 Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT2B Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT2C Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT4 Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
5-HT6 Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Adenosine A2A Receptor Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Adenosine A3 Receptor Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Adrenergic Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Akt1 Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
Aldose Reductase Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha Receptor Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha Receptor Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha v Beta 3 Integrin Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha-1 Agonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha-Amylase Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
Alpha-Synuclein (alphaSyn or SNCA) Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
AMPA Receptor Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs
Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2022
Topics: Enzymes, Prescription Drugs
Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2022
Topics: Prescription Drugs, Drug Discovery
PDE 1 Inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
PDE 10 inhibitor - Pipeline Insight, 2022
Topics: Prescription Drugs
Medicated Intrauterine Devices - Market Insights, Competitive Landscape and Market Forecast–2026
Topics: Gynecological Devices, Prescription Drugs, Women's Health, Reproductive Health
Abilify - API Insight, 2022
Topics: Prescription Drugs
Akynzeo - API Insight, 2022
Topics: Prescription Drugs
alimta - API Insight, 2022
Topics: Prescription Drugs
Amitiza - API Insight, 2022
Topics: Prescription Drugs
Angiox - API Insight, 2022
Topics: Prescription Drugs
Aristada - API Insight, 2022
Topics: Prescription Drugs
Axiron - API Insight, 2022
Topics: Prescription Drugs
Azilect  - API Insight, 2022
Topics: Prescription Drugs
Baraklyud - API Insight, 2022
Topics: Prescription Drugs
Beleodaq - API Insight, 2022
Topics: Prescription Drugs
BeneFIX  - API Insight, 2022
Topics: Prescription Drugs
Bepanthene - API Insight, 2022
Topics: Prescription Drugs
Botox - API Insight, 2022
Topics: Prescription Drugs
Byetta - API Insight, 2022
Topics: Prescription Drugs
Cholbam - API Insight, 2022
Topics: Prescription Drugs
Cialis - API Insight, 2022
Topics: Prescription Drugs
Colcrys - API Insight, 2022
Topics: Prescription Drugs
Concerta - API Insight, 2022
Topics: Prescription Drugs
Copaxone - API Insight, 2022
Topics: Prescription Drugs
Crestor - API Insight, 2022
Topics: Prescription Drugs


Prev  | 29  | 30  | 31  | 32  | 33  | 34  | 35  | 36  | 37  | 38  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.